Fractyl Health, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
Fractyl Health, Inc. (GUTS) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 1.49 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Shareholders' Equity
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-08-10
- Fractyl Health, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-12-31 was 2.20M shares.
- Fractyl Health, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-09-30 was -1.26M shares, a 456.68% decline year-over-year.
- Fractyl Health, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-06-30 was 190.19K shares, a 60.95% decline year-over-year.
- Fractyl Health, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-03-31 was 2.11M shares, a 1.30% decline year-over-year.
- Fractyl Health, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 3.25M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | 1.49M shares 10-Q · filed 2026-08-10 | ||||
| 2025-12-31 | 2.20M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | 948.81K shares derived: sum of 2 quarters · filed 2026-05-12 | 1.14M shares derived: sum of 3 quarters · filed 2026-05-12 | 3.25M shares 10-K · filed 2026-03-24 | |
| 2025-09-30 | -1.26M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-12 | -1.07M shares derived: sum of 2 quarters · filed 2026-05-12 | 1.05M shares 10-Q · filed 2026-05-12 | 2.40M shares 10-Q · filed 2025-11-12 | |
| 2025-06-30 | 190.19K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | 2.30M shares 10-Q · filed 2025-08-12 | |||
| 2025-03-31 | 2.11M shares 10-Q · filed 2025-05-13 | ||||
| 2024-09-30 | 352.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | 839.00K shares derived: sum of 2 quarters · filed 2024-11-12 | 2.98M shares 10-Q · filed 2024-11-12 | ||
| 2024-06-30 | 487.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | 2.63M shares 10-Q · filed 2024-08-14 | |||
| 2024-03-31 | 2.14M shares 10-Q · filed 2024-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B |